<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01338844</url>
  </required_header>
  <id_info>
    <org_study_id>MI_vs_DCI_Oo_q</org_study_id>
    <nct_id>NCT01338844</nct_id>
  </id_info>
  <brief_title>Role of Myo-inositol and D-chiro-inositol on Oocyte Quality</brief_title>
  <official_title>A Prospective, Randomized, Double Blind, Study on the Clinical Efficacy Myo-inositol Versus D-chiro-inositol in Women Undergoing in Vitro Fertilization Embryo Transfer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AGUNCO Obstetrics and Gynecology Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research Center for Reproductive Medicine Villa Mafalda</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Raffaele University Hospital, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AGUNCO Obstetrics and Gynecology Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Controlled ovarian hyperstimulation with gonadotropins is an integral part of the various
      stimulation protocols for patients undergoing in-vitro fertilization (IVF) and other Assisted
      Reproductive Technologies (ART) such as intracytoplasmic sperm injection (ICSI).

      The hormonal control of multiple follicular growth and maturation is a critical part of ART
      procedures since it maximizes the yield of embryos to be transferred, thus increasing the
      cumulative pregnancy rate.

      Recent studies have shown the efficacy of myo-inositol (MI) supplementation as a simple and
      highly effective treatment in order to improve oocyte quality in patients undergoing IVF.
      Indeed, it was previously shown that MI follicular fluid (FF) concentration is a reliable
      predictor of oocyte quality. High MI concentration in the FF directly correlates with high
      oocyte and embryo quality.

      Another stereoisomer of Inositol was successfully used into clinical practice
      D-chiro-inositol (DCI). In particular, DCI supplementation was used to restore ovulation in
      hyperglycemic PCOS patients.

      In the present study we aim to compare MI versus DCI supplementation on oocyte quality of
      women undergoing IVF-ET
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of morphologically mature oocytes</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Total international units (IU) of recombinant FSH administrated</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>number of grade 1 embryos</measure>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>D-Chiro-inositol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive 1.2g/day of D-chiro-inositol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Myo-inositol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive 4g/day of myo-inositol</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Myo-inositol</intervention_name>
    <arm_group_label>Myo-inositol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>D-chito-Inositol</intervention_name>
    <arm_group_label>D-Chiro-inositol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women undergoing IVF treatments

          -  Body mass index &lt;28

          -  FSH &lt;10IU/L

          -  Normal uterine cavity, anatomy and functions

        Exclusion Criteria:

          -  PCOS

          -  Stage III or IV endometriosis

          -  Premature ovarian failure

          -  Poor responder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianfranco Carlomagno, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>AGUNCO Obstetrics and Gynecology Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vittorio Unfer, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>AGUNCO Obstetrics and Gynecology Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franco Lisi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center for Reproductive Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Enrico Papaleo, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Raffaele Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Scott Roseff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Palm Beach Center for Reproductive Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Center for Reproductive Medicine Villa Mafalda</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Agunco</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002 Jun;17(6):1591-6.</citation>
    <PMID>12042283</PMID>
  </reference>
  <reference>
    <citation>Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol. 2011 Nov;27(11):857-61. doi: 10.3109/09513590.2011.564687. Epub 2011 Apr 5.</citation>
    <PMID>21463230</PMID>
  </reference>
  <reference>
    <citation>Rizzo P, Raffone E, Benedetto V. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):555-61.</citation>
    <PMID>20712264</PMID>
  </reference>
  <reference>
    <citation>Papaleo E, Unfer V, Baillargeon JP, Chiu TT. Contribution of myo-inositol to reproduction. Eur J Obstet Gynecol Reprod Biol. 2009 Dec;147(2):120-3. doi: 10.1016/j.ejogrb.2009.09.008. Epub 2009 Oct 2. Review.</citation>
    <PMID>19800728</PMID>
  </reference>
  <reference>
    <citation>Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril. 2009 May;91(5):1750-4. doi: 10.1016/j.fertnstert.2008.01.088. Epub 2008 May 7.</citation>
    <PMID>18462730</PMID>
  </reference>
  <reference>
    <citation>Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999 Apr 29;340(17):1314-20.</citation>
    <PMID>10219066</PMID>
  </reference>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2011</study_first_submitted>
  <study_first_submitted_qc>April 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2011</study_first_posted>
  <last_update_submitted>May 31, 2011</last_update_submitted>
  <last_update_submitted_qc>May 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2011</last_update_posted>
  <keyword>Poor oocyte quality</keyword>
  <keyword>IVF failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inositol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

